ArticleJournal of translational medicine2013

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients.

Laura Ridolfi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.